Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 8
2003 2
2004 5
2005 4
2006 1
2007 4
2008 2
2009 1
2010 6
2011 4
2012 6
2013 4
2014 10
2015 8
2016 9
2017 7
2018 3
2019 2
2020 13
2021 22
2022 10
2023 12
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

121 results

Results by year

Filters applied: . Clear all
Page 1
Safety and efficacy of cipaglucosidase alfa plus miglustat versus alglucosidase alfa plus placebo in late-onset Pompe disease (PROPEL): an international, randomised, double-blind, parallel-group, phase 3 trial.
Schoser B, Roberts M, Byrne BJ, Sitaraman S, Jiang H, Laforêt P, Toscano A, Castelli J, Díaz-Manera J, Goldman M, van der Ploeg AT, Bratkovic D, Kuchipudi S, Mozaffar T, Kishnani PS; PROPEL Study Group. Schoser B, et al. Lancet Neurol. 2021 Dec;20(12):1027-1037. doi: 10.1016/S1474-4422(21)00331-8. Lancet Neurol. 2021. PMID: 34800400 Clinical Trial.
An integrated genetic analysis of epileptogenic brain malformed lesions.
Fujita A, Kato M, Sugano H, Iimura Y, Suzuki H, Tohyama J, Fukuda M, Ito Y, Baba S, Okanishi T, Enoki H, Fujimoto A, Yamamoto A, Kawamura K, Kato S, Honda R, Ono T, Shiraishi H, Egawa K, Shirai K, Yamamoto S, Hayakawa I, Kawawaki H, Saida K, Tsuchida N, Uchiyama Y, Hamanaka K, Miyatake S, Mizuguchi T, Nakashima M, Saitsu H, Miyake N, Kakita A, Matsumoto N. Fujita A, et al. Among authors: shiraishi h. Acta Neuropathol Commun. 2023 Mar 2;11(1):33. doi: 10.1186/s40478-023-01532-x. Acta Neuropathol Commun. 2023. PMID: 36864519 Free PMC article.
Significance of micro-EGFR T790M mutations on EGFR-tyrosine kinase inhibitor efficacy in non-small cell lung cancer.
Masuda T, Miura S, Sato Y, Tachihara M, Bessho A, Nakamura A, Miyawaki T, Yoshimine K, Mori M, Shiraishi H, Hamai K, Haratani K, Maeda S, Tabata E, Kitagawa C, Tanizaki J, Imai T, Nogami S, Yamamoto N, Nakagawa K, Hattori N. Masuda T, et al. Among authors: shiraishi h. Sci Rep. 2023 Nov 13;13(1):19729. doi: 10.1038/s41598-023-45337-3. Sci Rep. 2023. PMID: 37957228 Free PMC article.
Akinetopsia as epileptic seizure.
Sakurai K, Kurita T, Takeda Y, Shiraishi H, Kusumi I. Sakurai K, et al. Among authors: shiraishi h. Epilepsy Behav Case Rep. 2013 May 20;1:74-6. doi: 10.1016/j.ebcr.2013.04.002. eCollection 2013. Epilepsy Behav Case Rep. 2013. PMID: 25667833 Free PMC article.
Perampanel for nonepileptic myoclonus in Angelman syndrome.
Kawano O, Egawa K, Shiraishi H. Kawano O, et al. Among authors: shiraishi h. Brain Dev. 2020 May;42(5):389-392. doi: 10.1016/j.braindev.2020.02.007. Epub 2020 Mar 10. Brain Dev. 2020. PMID: 32164978 Free article.
104-week efficacy and safety of cipaglucosidase alfa plus miglustat in adults with late-onset Pompe disease: a phase III open-label extension study (ATB200-07).
Schoser B, Kishnani PS, Bratkovic D, Byrne BJ, Claeys KG, Díaz-Manera J, Laforêt P, Roberts M, Toscano A, van der Ploeg AT, Castelli J, Goldman M, Holdbrook F, Sitaraman Das S, Wasfi Y, Mozaffar T; ATB200-07 Study Group. Schoser B, et al. J Neurol. 2024 May;271(5):2810-2823. doi: 10.1007/s00415-024-12236-0. Epub 2024 Feb 28. J Neurol. 2024. PMID: 38418563 Free PMC article. Clinical Trial.
Influence of background cardiovascular risk factors on VEGF inhibitor-related adverse vascular events in patients with non-small cell lung cancer: a retrospective study.
Naito T, Minegishi Y, Shiraishi H, Hoshino T, Maeda J, Yokota T, Ikeda S, Akihiko M, Seike M. Naito T, et al. Among authors: shiraishi h. J Cancer Res Clin Oncol. 2023 Oct;149(13):12435-12442. doi: 10.1007/s00432-023-05092-4. Epub 2023 Jul 13. J Cancer Res Clin Oncol. 2023. PMID: 37439826
Sirolimus for epileptic seizures associated with focal cortical dysplasia type II.
Kato M, Kada A, Shiraishi H, Tohyama J, Nakagawa E, Takahashi Y, Akiyama T, Kakita A, Miyake N, Fujita A, Saito AM, Inoue Y. Kato M, et al. Among authors: shiraishi h. Ann Clin Transl Neurol. 2022 Feb;9(2):181-192. doi: 10.1002/acn3.51505. Epub 2022 Jan 18. Ann Clin Transl Neurol. 2022. PMID: 35040598 Free PMC article. Clinical Trial.
121 results